Provided by Tiger Trade Technology Pte. Ltd.

Klotho Neurosciences, Inc.

0.5242
0.0000
Volume:- -
Turnover:1.17M
Market Cap:56.61M
PE:-1.72
High:0.5242
Open:0.5242
Low:0.5242
Close:0.5242
52wk High:3.91
52wk Low:0.1135
Shares:108.00M
Float Shares:98.09M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3046
EPS(LYR):-0.3195
ROE:-198.28%
ROA:-71.63%
PB:5.70
PE(LYR):-1.64

Loading ...

Company Profile

Company Name:
Klotho Neurosciences, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.